BrightSpring Health Services, Inc. (BTSG)
NEUTRALFondamental
67
Prix
$56.63
Capitalisation boursière
$11.62B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilan & Liquidités
Chiffre d'affaires
$14.37B
12 derniers mois (au 30/06/2026)
Résultat net
$366M
12 derniers mois (au 30/06/2026)
Flux de trésorerie libre
$395M
Capitaux propres totaux
$1.88B
Passif total
$4.53B
Ratio de liquidité général
1.59
Couverture des intérêts
2.94
Dette/EBITDA
5.20
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$71.31
Prix actuel
$56.63
Marge de sécurité
+20.6%
Fourchette de juste valeur
$56.87 - $85.75
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
36.05
ROE
10.2%
Ratio P/B
5.75
P/FCF
29.26
Marge brute
12.4%
ROIC
8.0%
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
8.0%
WACC
13.2%
ROIC − WACC
-5.2 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Critères d'analyse fondamentale
Réussi (18)
- EPS shows upward trend
- Price CAGR 86.00%
- ROIC 8.0%
- P/FCF 29.26
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 19.0%
- Revenue Growth 5Y 18.3%
- Analyst Consensus 96% Buy
- Earnings Surprise avg 17.2%
- PEG Ratio 0.68
- Earnings Quality (OCF/NI) 1.38
- Net Margin Trend 2.5% vs 0.6%
- Piotroski F-Score 7/9
Échoué (8)
- Gross Margin 12.4%
- P/B Ratio 5.75
- Operating Margin 3.1%
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Share Dilution 9.2%
Indisponible (1)
- Dividend Payout NaN%
Score F de Piotroski
Santé financière solide
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Émission de nouvelles actions, diluant la participation
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 51 |
| Ms. Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | 44 |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 52 |
| Ms. Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | 48 |
| Mr. Scott Greenwell Pharm.D. | Executive VP & President of PharMerica | - |
| Mr. Charles H. Wardrip | Chief Information Officer | - |
Risque d'audit
7
Risque du conseil
9
Risque de rémunération
8
Risque droits des actionnaires
8
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for BTSG, sourced from Markets Gazette.
- 2/27/2026NEUTRALBrightSpring (BTSG) Earnings Call Transcript
Markets Gazette reports that BrightSpring Health Services, Inc. (BTSG) held its earnings call on February 27, 2026. However, the detailed content of the transcript is not yet publicly available. Without access to specific financial data, future guidance, or management commentary, investors lack concrete elements to assess the company's performance or outlook. The absence of information prevents a clear directional analysis, leaving the stock in a holding pattern. The market will remain in suspense until the details are published, which could then trigger significant movements once key data points are released.
via Markets Gazette